Tag results:
cyclin D1
Intestinal Cell News
MICAL1 Inhibits Colorectal Cancer Cell Migration and Proliferation by Regulating the EGR1/β-Catenin Signaling Pathway
[Biochemical Pharmacology] MICAL1 has been reported to be involved in the malignant processes of several types of cancer cells, however, the roles of MICAL1 in colorectal cancer (CRC) have not been well-characterized. Researchers investigated the cellular functions and molecular mechanisms of MICAL1 in CRCs.
Mammary Cell News
Triple Targeting of Breast Tumors Driven by Hormonal Receptors and HER2
[Molecular Cancer therapeutics] Investigators tested the activity of co-targeting of estrogen receptor, HER2, and cyclin-dependent kinases 4/6 therapy with tucatinib, palbociclib, and fulvestrant in HR+/HER2+ human breast tumor cell lines and xenograft models.
Hepatic Cell News
Pre-mRNA Processing Factor 19 Functions in DNA Damage Repair and Radioresistance by Modulating Cyclin D1 in Hepatocellular Carcinoma
[Molecular Therapy-Nucleic Acids] Analysis of The Cancer Genome Atlas data and the authors' tumor models after ionizing radiation treatment indicated that increased expression of pre-mRNA processing factor 19 was positively correlated with DNA damage repair.
Muscle Cell News
Angptl2 Gene Knockdown Is Critical for Abolishing Angiotensin II-Induced Vascular Smooth Muscle Cell Proliferation and Migration
[Biochemistry and Cell Biology] Wistar-Kyoto rats and spontaneously hypertensive rats were used to detect the expression of Angptl2. Angiotensin II stimulated vascular smooth muscle cells to mimic hypertension in vitro.
Pancreatic Cell News
Type IIB PKA Is Highly Expressed in β Cells and Controls Cell Proliferation via Regulating Cyclin D1 Expression
[FEBS Journal] Investigators found that the RIIB subunit of protein kinase A is expressed specifically by β cells of mouse and human islets.
Mesenchymal Cell News
JAZF1, YWHAE, and BCOR Gene Translocation in Primary Extrauterine Low-Grade and High-Grade Endometrial Stromal Sarcomas
[Histopathology] In extrauterine low-grade endometrial stromal sarcoma (LG-ESS), the positive rate of JAZF1 gene rearrangement was significantly lower than in uterine LG-ESS, limiting the value of JAZF1 gene translocation for diagnosis.